Additionally, an HDAC inhibitor suberoylanilide hydroxamic acid (SAHA) was also shown to preferentially suppress cancer cells with p53 mutations by inhibiting HDAC6, an essential positive regulator of HSP90 (Figure 1) [133]. The gene discussed is TP53; the disease is cancer.